CTRI/2022/05/042669Not yet recruiting未知
Clinical efficacy and safety of non vitamin K anticoagulants compared to vitamin K anticoagulants in treatment of atrial fibrillation patients
srm college of pharmacy0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Atrial fibrillation patients
Exclusion Criteria
- •Patient with anitcoagulant therapy for a condition other than AF n
- •Pregnant and lactating women.
- •Patient with liver disease ( acute clinical hepatitis , chronic active hepatitis , cirrhosis )
Investigators
Similar Trials
Recruiting
Not Applicable
The efficacy and Safety of non-vItamiN K antaGonist oraL anticoagulants for intermEdiate stroke risk in patients with Atrial Fibrillation (SINGLE AF study)Diseases of the circulatory systemKCT0005141Yonsei University Health System, Severance Hospital1,800
Recruiting
Phase 2
A study to assess the safety of non-vitamin K antagonist oral anticoagulants on high-risk gastrointestinal endoscopic proceduresAll diseases that require high-risk gastrointestinal endoscopic procedures such as endoscopic polypectomy, endoscopic mucosal resection, endoscopic submucosal dissection, endoscopic balloon dilation, endoscopic mucosal ablation or percutaneous endoscopic gastrostomyJPRN-UMIN000018284Osaka International Cancer Institute50
Completed
Not Applicable
Evaluation of the Clinical use of vitamin K supplementation in post-menopausal women with OsteopeniaOsteopenia/osteoporosisMusculoskeletal DiseasesISRCTN61708241niversity Health Network, Toronto (Canada)440
Completed
Not Applicable
Prospective study of non-vitamin K antagonist oral anticoagulants (NOACs) management in Japanese patients with deep vein thrombosis and pulmonary embolism (DVT/PE)Venous thrombosisJPRN-UMIN000023747Department of Cardiology and Nephrology, Mie University Graduate School of Medicine1,000
Completed
Phase 4
Vitamin K antagonist (VKA) therapy versus New Oral Anticoagulants (NOACs) therapy in patients with currently well controlled VKA therapy for non-valvular atrial fibrillation: a pilot studyatrial fibrillationcardiac arrhythmiaNL-OMON41389niversitair Medisch Centrum Groningen240